JO
ELOS

John Overdeck’s Syneron Medical Ltd ELOS Stock Holding History

John Overdeck’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-378,695
Closed -$4.15M – 3462
2017
Q2 		$4.15M Sell
378,695
-67,627
-15% -$742K 0.02% 962
2017
Q1 		$4.71M Buy
446,322
+208,610
+88% +$2.02M 0.02% 965
2016
Q4 		$2M Buy
237,712
+78,643
+49% +$616K 0.01% 1491
2016
Q3 		$1.14M Buy
159,069
+95,524
+150% +$664K ﹤0.01% 1866
2016
Q2 		$489K Buy
63,545
+18,375
+41% +$131K ﹤0.01% 2266
2016
Q1 		$330K Sell
45,170
-4,062
-8% -$29.1K ﹤0.01% 2330
2015
Q4 		$380K Sell
49,232
-93,326
-65% -$712K ﹤0.01% 2123
2015
Q3 		$1.02M Sell
142,558
-38,620
-21% -$371K 0.01% 1184
2015
Q2 		$1.92M Sell
181,178
-60,353
-25% -$707K 0.01% 1231
2015
Q1 		$2.99M Buy
241,531
+162,562
+206% +$1.8M 0.01% 954
2014
Q4 		$737K Buy
78,969
+12,516
+19% +$121K ﹤0.01% 1519
2014
Q3 		$666K Sell
66,453
-11,839
-15% -$120K ﹤0.01% 1204
2014
Q2 		$808K Sell
78,292
-22,661
-22% -$245K ﹤0.01% 1414
2014
Q1 		$1.26M Buy
100,953
+48,864
+94% +$579K 0.01% 1113
2013
Q4 		$640K Buy
52,089
+40,067
+333% +$416K ﹤0.01% 1558
2013
Q3 		$103K Sell
12,022
-54,200
-82% -$468K ﹤0.01% 1743
2013
Q2 		$576K Buy
+66,222
New +$592K ﹤0.01% 1342

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 24.6% 1-Year Est. Return

John Overdeck's ELOS Position: Q3 2017 in Review

John Overdeck sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 378,695 shares — an estimated $4.15M sold.

John Overdeck first reported a position in ELOS in Q2 2013 and held it in 17 quarters. The position peaked at $4.71M in Q1 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • John Overdeck reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • John Overdeck sold 378,695 Syneron Medical Ltd shares in Q3 2017, an estimated $4.15M.
  • John Overdeck first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 17 quarters.
  • John Overdeck's Syneron Medical Ltd position peaked at $4.71M in Q1 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Two Sigma Investments's 13F filing for Q3 2017, filed 14 Nov 2017.